Concepedia

Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure

Alessandro Granito, Sara Marinelli, Eleonora Terzi, Fabio Piscaglia, Matteo Renzulli, Laura Venerandi, Francesca Benevento, Luigi Bolondi

Digestive and Liver Disease · 2015 · 95 citations · 23 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyChemotherapyOncology PharmacotherapyHepatobiliary CancerHepatocellular CarcinomaHepatocellular Carcinoma PharmacotherapyLiver CancerMalignant NeoplasmsToxicity ManagementCapecitabine-based TherapyHepatic TumorsHepatocellular Carcinoma TreatmentLiver Tumor TherapyOxaliplatin-based TherapySecond-line ChemotherapySorafenib Therapy

References

23

Sorafenib in Advanced Hepatocellular Carcinoma

Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al. · New England Journal of Medicine · 2008 · 13K citations · Full text

Medicine, Oncology, Pharmacology +12

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

Medicine, Oncology, Pharmacotherapy +11

Sorafenib in Advanced Hepatocellular Carcinoma

재연 정 · 2008 · 5.6K citations

Medicine, Oncology, Pharmacology +12

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

Journal of Hepatology · 2012 · 5.2K citations

Medicine, Oncology, Surgery +12

EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer

Josep M. Llovet, Michel Ducreux, Riccardo Lencioni et al. · 2012 · 1.5K citations

Medicine, Oncology, Radiation Oncology +17